Session Details
[1-S]The Future of Pharmacological Research as Envisioned by the Next Generation of Scientists
Mon. Mar 16, 2026 3:50 PM - 5:20 PM JST
Mon. Mar 16, 2026 6:50 AM - 8:20 AM UTC
Mon. Mar 16, 2026 6:50 AM - 8:20 AM UTC
Room 7(B203)
Chair:Yasushi Yabuki(Institute of Molecular Embryology and Genetics, Kumamoto University), Kiyoshi Ishikawa(Tanabe Pharma Corporation)
In recent years, rapid advances in bioinformatics and artificial intelligence (AI) have led to increasingly diverse research methodologies and the gradual blurring of boundaries between academic disciplines. In this symposium, we invite next-generation researchers who are actively engaged in both the pharmaceutical industry and academia to present not only their current research but also their perspectives on the future directions of their reserch. We also ask each speaker to share their views on how the field of pharmacology should evolve in the years ahead. Following the individual presentations, we will hold a panel discussion involving participants from the floor including students, early-career researchers, mid-career, and senior scientists to facilitate an open and lively discussion on the future vision of pharmacological research.
[1-S-80]Unraveling neurodegenerative mechanisms mediated by RNA secondary structures: Implications for pharmacological research
*Yasushi Yabuki1,2 (1. Dept. Gen. Neuro., IMEG, Kumamoto Univ., 2. Grad. Pharm., Kumamoto Univ.)
[1-S-81]iPS Cell-Based Drug Discovery Paves the Way for a New Approach to ALS Treatment
- Integrated Basic and Clinical Loop Pharmacology
*Satoru Morimoto1 (1. Keio University Regenerative Medicine Research Center)
[1-S-82]Drug repositioning research for cardiovascular and renal diseases focusing on kampo medicine and antidepressants
*Hideaki Tagashira1, Tomohiro Numata1 (1. Akita Univ.)
[1-S-83]Pharmacological approaches uncover the novel mechanism of somatosensory system
*Yuta Kohro1,2, Makoto Tsuda2 (1. Dept. Pathophysiology, Grad. Sch. Pharm. Sci., Kyushu Univ. , 2. Dept. Mol. Syst. Pharmacol., Grad. Sch. Pharm. Sci., Kyushu Univ.)
[1-S-84]Nucleic Acid Drug Discovery in Rare Muscular Diseases: A Case Study from My Experience in Pharmaceutical Drug Development
*Kiyoshi Ishikawa1, Tetsuhiro Kakimoto1, Shumpei Murata1, Hiroaki Sawamoto1 (1. Tanabe Pharma Corporation)
